Hemostasis Products Market, Share, Growth, Trends and Forecast to 2030: Global Market Insights The hemostasis products market is set to experience robust growth through 2030 owing to expanding geriatric population. Additionally, improving global healthcare infrastructure is likely to further bolster industry growth over the forecast timeline. Notably, industry players have been adopting profitable strategies to broaden their product offerings, thereby enhancing the overall dynamics of the hemostasis products market. For instance, in February 2021, Teleflex Inc., a medical and surgical instruments manufacturer, acquired Z-Medica, a leading manufacturer of hemostatic products. With this acquisition, Teleflex gained Z-Medica's QuickClot brand of products, the firm's proprietary technology that expedites the clotting cascade, which helps achieve hemostasis faster. Browse key industry insights spread across 207 pages with 232 market data tables & 15 figures & charts from the report, “Hemostasis Products Market Analysis By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({Flowable, Thrombin, Synthetic Sealants, Fibrin}), Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents: https://www.gminsights.com/industryanalysis/hemostasis-products-market
To cite another instance, in February 2021, EndoClot Plus, Inc., a U.S.-based medical device company, received FDA approval for its EndoClot PHS, an innovative product that enables Gastroenterologists to stop bleeding promptly and effectively. The EndoClot PHS is a singleuse device that can be applied directly to the bleeding site. The FDA clearance was a milestone in furthering gastrointestinal patient care and supplemented the firm's expansion in the GI Endoscopy space. The hemostasis products market has been bifurcated on the basis of application, product, end-use, and region. © 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com